PHARMA SUPPLY LIMITED

Company number 04091023

3 active persons with significant control / 0 active statements

Mr Daniel Jr Osei-Bonsu (Active)

• Correspondence address: 54 The Mall, The Stratford Centre, London, England, E15 1XE
• Notified on: 27 March 2024
• Date of birth: September 1998
• Nationality: British
• Country of residence: England
• Nature of control: Has significant influence or control

Mr Daniel Osei-Bonsu (Active)

• Correspondence address: 54 The Mall, The Stratford Centre, London, England, E15 1XE
• Notified on: 25 March 2024
• Date of birth: November 1971
• Nationality: British
• Country of residence: England
• Nature of control: Has significant influence or control

Kalmak(Chemists) Limited (Active)

• Correspondence address: 54 The Mall, The Stratford Centre, London, England, E15 1XE
• Notified on: 16 January 2024
• Governing law: Company Act 2006
• Legal form: Limited Company
• Place registered: Uk
• Registration number: 01028220
• Incorporated in: United Kingdom
• Nature of control: Ownership of shares – 75% or more
• Nature of control: Ownership of voting rights - 75% or more

Mr Daniel Jr Osei-Bonsu (Ceased)

• Correspondence address: 54 The Mall, The Stratford Centre, London, England, E15 1XE
• Notified on: 24 March 2024
• Ceased on: 25 March 2024
• Date of birth: September 1998
• Nationality: British
• Country of residence: England
• Nature of control: Has significant influence or control

Mr Daniel Osei-Bonsu (Ceased)

• Correspondence address: 54 The Mall, The Stratford Centre, London, England, E15 1XE
• Notified on: 30 October 2020
• Ceased on: 24 March 2024
• Date of birth: November 1971
• Nationality: British
• Country of residence: England
• Nature of control: Has significant influence or control

Mr Ramiz Mufid Razouki Bahnam (Ceased)

• Correspondence address: A9, Marine Gate, Brighton, East Sussex, England, BN2 5TP
• Notified on: 6 April 2016
• Ceased on: 30 October 2020
• Date of birth: March 1973
• Nationality: British
• Country of residence: England
• Nature of control: Ownership of shares – 75% or more